| 1. |
- Hollmark, Malin, et al.
(författare)
-
A comparison of radiobiological models for light ion therapy
- 2007
-
Ingår i: The 11th Workshop of Ion Beams in Biology and Medicine, 25-29 September 2007, Heidelberg, Germany, ISSN 1013-4506, p. 47 (2007).
-
Konferensbidrag (populärvet., debatt m.m.)abstract
- Treatment planning for light ion therapy requires development of radiobiological models describing the effects of light ion irradiation on cellular survival. The aim of this work is to compare some of these radiobiological models currently in use. The benchmark cell line used in these studies is an AA human melanoma cell line, irradiated in vitro under aerobic conditions by 60Co and 10B5+ ions of different values of linear energy transfer (40, 80, 125 and 160 keV/μm). The models used to analyze the data were: the standard linear-quadratic (LQ) model, the repairable-conditionally repairable (RCR) model, the probabilistic two-stage (P2S) model, Katz’s cellular track structure theory (TST), and the local effect model (LEM).
|
|
| 2. |
|
|
| 3. |
- Berndt, Carsten, et al.
(författare)
-
Chelation of lysosomal iron protects against ionizing radiation.
- 2010
-
Ingår i: Biochemical Journal. - 0264-6021 .- 1470-8728. ; 432:2, s. 295-301
-
Tidskriftsartikel (refereegranskat)abstract
- Ionizing radiation causes DNA damage and consequent apoptosis, mainly due to the production of hydroxyl radicals (HO•) that follows radiolytic splitting of water. However, superoxide (O2•-) and H2O2 also form and induce oxidative stress with resulting LMP (lysosomal membrane permeabilization) arising from iron-catalysed oxidative events. The latter will contribute significantly to radiation-induced cell death and its degree largely depends on the quantities of lysosomal redox-active iron present as a consequence of autophagy and endocytosis of iron-rich compounds. Therefore radiation sensitivity might be depressed by lysosome-targeted iron chelators. In the present study, we have shown that cells in culture are significantly protected from ionizing radiation damage if initially exposed to the lipophilic iron chelator SIH (salicylaldehyde isonicotinoyl hydrazone), and that this effect is based on SIH-dependent lysosomal stabilization against oxidative stress. According to its dose-response-modifying effect, SIH is a most powerful radioprotector and a promising candidate for clinical application, mainly to reduce the radiation sensitivity of normal tissue. We propose, as an example, that inhalation of SIH before each irradiation session by patients undergoing treatment for lung malignancies would protect normally aerated lung tissue against life-threatening pulmonary fibrosis, whereas the sensitivity of malignant lung tumours, which usually are non-aerated, will not be affected by inhaled SIH.
|
|
